Express Pharma

GNH brings malaria relief to Yemen’s conflict zone

3

The consignment contained 1, 20,000 Mefloquine tablets and Primaquine 45mg which were delivered in a record time of three weeks

GNH India has successfully exported one of the largest orders for anti-malarial pharmaceuticals for a conflict zone in Yemen. The consignment contained 1, 20,000 Mefloquine tablets and Primaquine 45mg which were delivered in a record time of three weeks from receipt of order. The consignment was sent to a local aid agency operating in Oman; from there it was delivered to Yemen by road. Most established pharma companies fear to work in these zones due to the implication of US Sanctions, but GNH India has set an example by giving importance to humanity rather than business.

Dr Piyush Gupta, Associate Director, GNH India, commented, “It is an accomplishment for GNH India to export such a big order to Yemen in a time span of three weeks. Such consignments are a testimony to our belief that everyone in all parts of the world deserves access to proper medicines irrespective of their geographical boundaries or political affiliations. We ensured that despite the obstacles placed in our way, the conflict ridden citizens of Yemen would receive medicines that are in dire need in of these drugs.”

Mefloquine is commonly used to fight malaria and used by travellers around the world to prevent malaria when visiting places where malaria is common. On the other hand, Primaquine is used with other medications to prevent and treat malaria. It is used when the primary medicine (such as Mefloquine) have killed the malaria parasites living in red blood cells.

Comments are closed.